-
41
deutetrabenazine for the treatment of chorea associated with Huntington’s disease
Published 2022-06-01“…Chorea is a movement disorder present in multiple neurologic diseases that causes involuntary and irregular muscle movements theorized to be stemming from high dopamine levels. …”
Get full text
Article -
42
Successful Extracorporeal Membrane Oxygenation (ECMO) Use without Systemic Anticoagulation for Acute Respiratory Distress Syndrome in a Patient with Aneurysmal Subarachnoid Hemorrh...
Published 2019-01-01“…Unfortunately, ECMO has been traditionally contraindicated in patients with hemorrhagic neurologic diseases. The recent improvement in ECMO devices, increased utilization and experience with venovenous ECMO technologies among healthcare teams, and the use of ECMO without anticoagulation has expanded the potential populations that may benefit from ECMO. …”
Get full text
Article -
43
Constipations in elderly: diagnostics and treatment approach
Published 2011-03-01“…At investigation of the patient it is especially important to estimate history of drug intake, to pay the special attention to signs of obscure depression and anxiety, systemic and neurologic diseases and so- called «red flags». Constipation with delayed transit and megarectum are associated to the risk of fecal impaction, compression of urinary tract and stercoral colitis development, with intestinal perforation, blee- ding and suppuration.At treatment prescription it is necessary to take into account nature of constipation, features of clini- cal pattern, intestinal transit, incidental or persistent course. …”
Get full text
Article -
44
Evaluating the Cause of Death in Obese Individuals: A Ten-Year Medical Autopsy Study
Published 2015-01-01“…Obese individuals were statistically more likely to die from pulmonary embolism and liver disease and less likely to die from neurologic diseases and nonischemic heart disease. Conclusion. …”
Get full text
Article -
45
Neuroinflammation in Autism: Plausible Role of Maternal Inflammation, Dietary Omega 3, and Microbiota
Published 2016-01-01Get full text
Article -
46
Elevated Osteopontin Levels in Mild Cognitive Impairment and Alzheimer’s Disease
Published 2013-01-01“…Cerebrospinal fluid (CSF) and plasma samples were obtained from 35 AD patients, 31 MCI patients, and 20 other noninflammatory neurologic diseases (OND). Concentrations of OPN in the CSF and plasma were determined by enzyme-linked immunosorbent assay. …”
Get full text
Article -
47
Polygenic burden of short tandem repeat expansions promotes risk for Alzheimer’s disease
Published 2025-01-01“…As pathogenic expansions of STR cause over 30 neurologic diseases, it is important to ascertain whether STRs may also be implicated in AD risk. …”
Get full text
Article -
48
Repression of the stress granule protein G3BP2 inhibits immune checkpoint molecule PD‐L1
Published 2025-02-01Get full text
Article -
49
Tissue-specific roles of de novo DNA methyltransferases
Published 2025-01-01“…Overall, the expression patterns of DNMTs across tissues provide insights into potential therapeutic applications for treating neurologic diseases, cancer, and osteoporosis.…”
Get full text
Article -
50
Microglia modulate the cerebrovascular reactivity through ectonucleotidase CD39
Published 2025-01-01Get full text
Article -
51
Prognostic Value of CXCL13, CCL11, and CCL20 Chemokines in Multiple Sclerosis
Published 2024-12-01“…<b>Methods:</b> Forty-two patients with MS were enrolled, along with 22 controls, 12 of the controls were idiopathic intracranial hypertension (IIH) patients, and 10 of the controls were other neurologic diseases (OND). Chemokine levels were measured using enzyme-linked immunosorbent assay (ELISA) in serum and cerebrospinal fluid (CSF) samples. …”
Get full text
Article -
52
-
53
Peripheral proteinopathy in neurodegenerative diseases
Published 2025-01-01“…Abstract Proteinopathies in neurology typically refer to pathological changes in proteins associated with neurological diseases, such as the aggregation of amyloid β and Tau in Alzheimer’s disease, α-synuclein in Parkinson’s disease and multiple system atrophy, and TAR DNA-binding protein 43 in amyotrophic lateral sclerosis and frontotemporal dementia. …”
Get full text
Article -
54
Clinically probable RBD is an early predictor of malignant non-motor Parkinson’s disease phenotypes
Published 2025-01-01Get full text
Article -
55
Ruptured Suprasellar Dermoid Cyst presenting with Chemical Meningitis and Blindness
Published 2025-02-01Get full text
Article -
56
Key considerations in setting up a therapeutic plasma exchange service for neurology patients
Published 2025-01-01“…Therapeutic plasma exchange (TPE) is effective in the treatment of both neurological and non-neurological diseases. It is highly efficacious when used appropriately but has significant associated risks. …”
Get full text
Article -
57
-
58
-
59
-
60
Sensorineural Hearing Loss and Celiac Disease: A Coincidental Finding
Published 2009-01-01“…BACKGROUND: Celiac disease (CD) can be associated with a variety of extraintestinal manifestations, including neurological diseases. A new neurological correlation has been found between CD and sensorineural hearing loss (SNHL).…”
Get full text
Article